Aspire Biopharma Holdings (ASBP) Debt Ratio (2023 - 2026)
Aspire Biopharma Holdings (ASBP) posted quarterly Debt Ratio of 0.07 for Q1 2026, down 72.38% year-over-year from 0.25 in Q1 2025, and down 96.7% quarter-over-quarter from 2.13 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Debt Ratio (2023 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Debt Ratio for 4 consecutive years, with 0.07 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 72.38% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (down 72.38% YoY), while the FY2025 annual figure was 2.13, down 92.29% from the prior year.
- Debt Ratio fell to 0.07 in Q1 2026 per ASBP's latest filing, from 2.13 in the prior quarter.
- Across five years, Debt Ratio topped out at 27.59 in Q4 2024 and bottomed at 0.0 in Q4 2023.
- Historically, Debt Ratio has averaged 3.63 across 4 years, with a median of 0.25 in 2025.
- Annual changes were most pronounced in 2024 — Debt Ratio surged 2225929.64% — and 2025, when it tumbled 92.29%.
- Aspire Biopharma Holdings' Debt Ratio stood at 0.0 in 2023, then soared by 2225929.64% to 27.59 in 2024, then sank by 92.29% to 2.13 in 2025, then plunged by 96.7% to 0.07 in 2026.
- Business Quant data shows ASBP's Debt Ratio at 0.07 in Q1 2026, 2.13 in Q4 2025, and 1.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Aspire Biopharma Holdings | 8.30 Mn | -3.86 Mn | -30,086.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.07 |
| Dec 31, 2025 | 2.13 |
| Sep 30, 2025 | 1.97 |
| Jun 30, 2025 | 0.50 |
| Mar 31, 2025 | 0.25 |
| Dec 31, 2024 | 27.59 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.00 |